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Abstract
Here we report the effects of subchronic 3, 4-methylene-
dioximethamphetamine (MDMA) on the elevated plus-
maze, a widely used animal model of anxiety. Rats ex-
posed to a mild chronic stress (MCS) protocol received 
intracerebroventricular microinjections of the selective 
serotonin reuptake inhibitor (SSRI) – fluoxetine (2.0 ug/
ul) or MDMA, (2.0 ug/ul) for seven days. On the eighth 
day rats were tested in the elevated plus-maze. Our re-
sults showed that sub-chronic MDMA interacted with 
MCS leading to a decrease in anxiety-related behaviors 
including: percentage of open arms entries (F 
[2, 26]
 = 4.00; 
p = 0.031), time spent in the open arms (F 
[2, 26]
 = 3.656; 
p = 0.040) and time spent in the open arms extremities 
(F 
[2, 26]
 = 5.842; p = 0.008). These results suggest a po-
tential effect of MDMA in the reversion of the emotional 
significance of aversive stimuli.
Keywords: MDMA, fluoxetine, elevated plus-maze, 
anxiety, serotonin, mild chronic stress
Resumen
Reportamos aquí los efectos de la administración sub-
crónica de 3, 4-metilendioximetanfetamina (MDMA) 
sobre el laberinto en cruz elevado, un modelo animal 
de ansiedad ampliamente utilizado. Las ratas fueron 
expuestas a un protocolo de estrés crónico moderado 
(MCS) y recibieron microinyecciones intra-cerebroven-
triculares del inhibidor selectivo de la recaptación de se-
rotonina (SSRI)-fluoxetina (2,0 ug/ul) o de MDMA (0,2 
ug/ul) durante siete días. En el octavo día las ratas fueron 
probadas en el laberinto en cruz elevado. Los resultados 
mostraron que la administración subcrónica de MDMA 
interactuó con el MCS, llevando a un decremento de los 
comportamientos relacionados con la ansiedad, inclu-
yendo: porcentaje de entradas a los brazos abiertos (F 
[2, 
26]
 = 4.00; p = 0.031), el tiempo empleado explorando los 
brazos abiertos (F 
[2, 26]
 = 3.656; p = 0.040) y el tiempo 
empleado explorando las extremidades de los brazos 
abiertos (F 
[2, 26]
 = 5.842; p = 0.008). Estos resultados 
sugieren un potencial efecto de MDMA en la reversión 
del significado emocional de los estímulos aversivos.
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Resumo
Os efeitos da administração sub-crônica de 3, 4-metile-
nedioximetanfetamina (MDMA) no labirinto em cruz 
elevado, um modelo amplamente utilizado no estudo da 
ansiedade, foram testados. Ratos submetidos a um pro-
tocolo de estresse crônico moderado (MCS) receberam 
micro injeções intra cérebro ventriculares do inibidor 
seletivo da recaptação de serotonina (SSRI)-fluoxetina 
(2.0ug/ul) ou MDMA (2.0 ug/ul) durante sete dias. No 
oitavo dia, os ratos foram testados no labirinto em cruz 
elevado. Os resultados sugerem que a administração 
sub-crônica de MDMA interagiu com o MCS levando 
à diminuição dos comportamentos relacionados com 
ansiedade, incluindo: porcentagem de entradas aos 
braços abertos (F 
[2, 26]
 = 4.00; p = 0.031), o tempo gasto 
explorando os braços abertos (F 
[2, 26]
 = 3.656; p = 0.040) 
e o tempo gasto explorando as extremidades dos braços 
abertos (F 
[2, 26]
 = 5.842; p = 0.008)
Palavras-chave: MDMA, fluoxetina, labirinto em cruz 
elevado, ansiedade, serotonina, estresse crônico mo-
derado
Generalized anxiety disorder (GAD) is a common 
mental illness. Given its co-morbidity with depres-
sion, it has received much attention in recent years. 
Some of the symptoms present in GAD depend on 
serotonergic mechanisms. It has been reported that 
increased serotonin (5-HT) release induces anxiety 
enhancement in both animal models and human 
clinics (Kakui et al., 2009; Khan et al., 2006). Se-
veral animal models of anxiety have been used in 
the screening of anxiolytic or anxiogenic proper-
ties of compounds, including the elevated plus-
maze (EPM), social interaction tests, open fields, 
etc. (Dunn et al., 1989). Some 5-HT1a agonists 
(i.e. buspirone) show an inverted-U-shaped dose-
response curve in some animal models of anxiety 
such as the Vogel conflict test (Vaidya et al., 2005).
Evidences supporting the role of 5-HT in the 
physiopathology of GAD include the anxiogenic-
like effect of selective 5-HT reuptake inhibitors 
(SSRIs) —as fluoxetin— in early treatment for 
depression in human clinics. SSRIs induce an initial 
period of enhanced anxiety and their anxiolytic or 
antidepressant effects only arise after prolonged 
treatment. This delayed effect has been explained 
by the ability of SSRIs (similar to that found in 
5-HT1a agonists) to inhibit the firing rate of sero-
tonergic neurons through the activation of somato-
dendritic receptors (Zhang et al., 2000).
3, 4-Methylenedioximethamphetamine (MD-
MA) is a strong monoaminergic reuptake inhibitor 
with an extremely high affinity for 5-HT trans-
porters (SERTs). MDMA reverses SERTs action, 
leading to a rapid enhancement in 5-HT release, 
even in the absence of incremented firing rate. The 
initial enhanced release is followed by the deple-
tion of serotonergic terminals. In addition MDMA 
blocks 5-HT reuptake and it also maybe inhibits 
monoaminooxidase (MAO). All these actions en-
hance the availability of 5-HT (Colado et al., 2001; 
Green et al., 1995; Iravani et al., 2000; Mlinar & 
Corradetti, 2003).
Different effects for MDMA on anxiety have 
been reported. For example acute administration 
of “moderate” doses of systemic MDMA (8-15mg/
Kg) in rats increase anxiogenic-like behaviors in 
the EPM and in the light-dark box (Lin et al., 1999; 
Maldonado & Navarro, 2000; Navarro & Maldo-
nado, 2002). Assuming that the commonly used 
dose by adult humans range between 100 and 120 
mg (2mg/Kg approximately) the 8-15 mg/Kg dose 
used by those authors range between fourfold and 
sevenfold and is “high” rather than “moderate”. 
Acute administration of (0, 1.25, 2.5, 5 mg /kg) of 
MDMA seems to have paradoxal effects, enhancing 
anxiety in EPMs and cat odor avoidance tests and 
reducing it in social interaction and footshock-
induced ultrasonic vocalization tests (Morley & 
McGregor, 2000). It was also found that lower do-
ses of MDMA (1.25 mg/Kg) significantly reduce 
aggressive behavior in the social interaction test. 
These paradoxal results could be explained assu-
ming that at lower doses there exists an interaction 
between MDMA and basal anxiety conditions lea-
ding to different effects.
In order to elucidate the possible interaction 
between MDMA and basal anxiety here we used 
the chronic unpredictable stress protocol (CUS) 
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sometimes referred as chronic mild stress (MCS). 
This protocol involves the single exposure to di-
fferent mild unpredictable stressors, at least two 
per day (Papp et al., 1996). There are many avai-
lable protocols varying between two weeks and 
four months. Some variations in the amount of the 
depressive-like effects induced by MCS and CUS 
have been also reported (Ducottet et al., 2003; Li 
et al., 2010). MCS induces acute 5-HT release fo-
llowed by a decrease in serotonergic neurons firing 
rate and partial desensitizitation of somatodendritic 
5-HT1a autoreceptors in the dorsal raphe (Bambi-
co et al., 2009; Ossowska et al., 2001). Previous 
research has also reported that exposure to unpre-
dictable stressors can increase anxiety in rodents 
(Matuszewich et al., 2007). However the precise 
role of MCS in general anxiety levels has not been 
fully demonstrated. Indeed there are many contra-
dictory reports (Bondi et al., 2008; Cunningham 
et al., 2009; Fokos & Panagis, 2010; Mitra et al., 
2005; Vyas & Chattarji, 2004). For some authors 
the exposure to CUS has no effect on unconditio-
ned response tasks as the EPM (Matuszewich et al., 
2002; Mitra et al., 2005). For some others however, 
the exposure to stressors induces an enhancement 
in the level of anxiety (Botelho et al., 2007; Dos 
Santos et al., 2010; Estanislau & Morato, 2005; Ha-
ta et al., 2001). The aim of this study is to compare 
the interaction between basal anxiety levels and the 
effects of both MDMA and fluoxetine on the EPM 
performance of rats previously exposed to MCS.
Experimental procedures
Animals
Thirty-two naive three months old male Wistar rats 
(320 ± 30 g) were used. All the animals were obtai-
ned from the animal facilities of the Universidad 
de los Andes. The subjects were housed in groups 
of four, in polypropylene cages (43 x 31 x 18 cm) 
and kept under a 12 h light/dark cycle (lights on 
at 07:00h). Rats had free access to food and water 
throughout the experiment. All experimental pro-
tocols employed in this work were performed in 
compliance with recommendations of the Colom-
bian Guidelines for Laboratory Animal Care (laws 
84/1989 and 8430/1993) which are based on the 
US National Institutes of Health Guide for Care 
and Use of Laboratory Animals (No. 86-23, revised 
1996). After the arrival at the laboratory, rats were 
allowed three days to acclimate to the vivarium 
conditions. All rats received two minutes of daily 
handling (to get familiar with the experimenters) 
for three days, before the beginning of the experi-
ments.
Surgery
Each animal was anesthetized with a mixture of 
Ketamine (RotexMédica, 75 mg/Kg) and Xylacine 
(Bayer, 5 mg/Kg), and fixed in a stereotaxic frame 
(Narishige). Lidocaine (Ropsohn Therapeutics, 
2 %) was subcutaneously administrated under the 
scalp. The incisor bar was set at 3.3 mm below the 
interaural line such that the skull was horizontal 
between Bregma and Lambda. A stainless steel 
guide cannula (9 mm), through which a microinjec-
tion needle could be inserted for drug infusion, was 
implanted aimed at the lateral ventricle (AP = 0.8 
mm; ML = +1.4 and DV = 2.4 mm, using Bregma as 
reference, Paxinos & Watson, 2007). The cannula 
was attached to the skull by means of acrylic resin 
and to two stainless steel screws. The rats were then 
returned to their cages. At the end of the surgery the 
cannula was sealed with a wire to protect it from 
obstruction. Before the rats returned to their cages, 
they received intramuscular vancomycin (Lilly). 
All rats were allowed a period of sis days for the 
recovery of the surgery.
Drugs
MDMA (Radian International) and fluoxetine 
(Genfar) were dissolved in saline solution (0.9 %) 
to concentrations of 2.5 and 2.0 ug/ul, respectively. 
Control animals received saline solution (0.9 %). 
Esteban et al. (2001), using microdyalisis showed 
that a dose of 15 mg/Kg led to a cerebral extrace-
llular concentration of 20 uM. In the same set of ex-
periments, they demonstrated that the intracerebral 
perfusion of 400 mM of MDMA led to an extraellu-
lar concentration between 10.4 and 19.5 uM. These 
extracellular concentrations are neurotoxic. For 
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these reasons and in order to prevent any neurotoxic 
effect we used a thousand times lower dose. It was 
also found that the intracerebroventricular infusion 
of 2.0 ug of MDMA induced self-administration 
(Braida & Sala, 2002) suggesting that this dose is 
effective with no potential neurotoxic effect.
Procedure
Mild chronic stress
The subjects were randomly assigned to one of two 
groups: exposed to mild chronic stress; (MCS[+]) 
or no exposed to mild chronic stress; (MCS[-]). 
MCS[-] animals were left in the vivarium with no 
other procedure than five minutes of daily handling. 
The seven days MCS protocol used was a modified 
version of that described by D’Aquila et al (1994). 
Briefly it consisted of one or two different stres-
sors per day i.e. inclination of the cage, change of 
partners, wet bedding, altered light–dark cycle, etc.
MCS[+] and MCS[-] animals were divided into 
three subgroups receiving intracerebroventricular 
fluoxetine, MDMA or saline solution once a day 
per seven days. All microinjections were done at 
a rate of 1ul/min, using a dental needle connected 
to a Hamilton syringe via a Tygo tubing. The total 
injected volume was 1ul. The displacement of an 
air bubble inside the tubing was used to monitor 
the progress of the microinjection. After receiving 
the microinjection each animal returned to its cage.
Elevated plus-maze
An elevated plus-maze, described in detail el-
sewhere was used (Cardenas et al., 2001). Briefly 
it consisted of two open arms (50 x 10 cm) crossed 
at right angles with two opposed arms of the same 
size. Two of the opposed arms were enclosed by 
wooden walls (40 cm high) except for the central 
part where the arms crossed. The whole apparatus 
was elevated 50 cm above the floor. To prevent the 
rats from falling, a rim of Plexiglas (1.0 cm high) 
surrounded the perimeter of the open arms. The 
experimental sessions were recorded by a video 
camera interfaced with a computer in an adjacent 
room and digitalized for later analysis. In order to 
record displacements from one place to the other in 
the plus-maze and to precisely locate where other 
behaviors occurred, the image of the elevated plus-
maze was virtually divided into 10 cm-squares. 
This also allowed the recording of the number of 
squares entered by an animal (which made possi-
ble to estimate the total distance run). An entry to 
any kind of arm was scored when all four feet were 
within that arm.
Along with the number of entries into and the ti-
me spent in each kind of arm, other behaviors were 
also analyzed: (a) number of entries into and time 
spent in the endings of the open arms; (b) groo-
ming: defined as the species-innate groom behavior 
beginning with the snout, progressing to the ears 
and ending with whole-body groom; (c) rearing: 
partial or total rising onto the hind limbs; (d) head 
dipping: exploratory movement of head and shoul-
ders over sides of the open arms and down towards 
the floor; (e) head out (horizontal scanning): ex-
ploratory movement of head and shoulders over 
sides of the open arms without directing towards 
the floor; (f) freezing: absence of any movements 
different than breathing for at least three seconds 
and (g) stretching (flat back approach): defined as 
the stretched cautious movement from one square 
to the next within the open arms. Displacements 
and behaviors were recorded using the software X 
Plo Rat (version 3.3).
Histology
After the end of experiments, all rats were anesthe-
tized with a lethal dose of penthobarbital (80 mg/
Kg). The animals were then transcardiacally perfu-
sed with 120ml of saline solution (0.9 %) followed 
by 200 ml of paraformaldehyde (4 %). The brains 
were then gently removed and maintained in the 
same paraformaldehyde solution for at least four 
days. After that period all the brains were coronally 
sectioned on a sliding vibratome (Vibratome 1500) 
and 60 um slices were obtained and treated for Nissl 
staining with Cresyl Violet to confirm the location 
of the cannula. All animals with cannulae in wrong 
locations were excluded from the study.
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Statistics
All data were analyzed using two-way ANOVA. 
When necessary, the comparison between the ave-
rages of the groups was done using the Newman 
Keuls test as post hoc test. Alpha was set at 0.05 
for all instances.
Results
(Please refer to Table 1 for all numeric F values 
for ANOVAs). Regarding to the number of entries 
into the open arms ANOVA showed significant 
differences for the treatment condition but not for 
the stress condition (F 
[2, 26]
 = 6.556; p = .005; F 
[1, 26]
 
= .057; p = .813). The interaction between the two 
factors was significant (F 
[2, 26]
 = 4.000; p = .031). 
The post hoc comparison of the averages of the 
groups (Student Newman-Keuls) showed that ani-
mals treated with fluoxetine entered less into the 
open arms when previously submitted to the stress 
condition (p < .05). The post hoc test also showed 
that animals without stress and treated with fluoxe-
tine entered more into the open arms than control 
Table 1 
Statistics (ANOVA) for all measures
Behavioral measure
Treatment (flx – MDMA) Stress (positive – negative) Interaction
F[2,26] P F[1,26] P F[2,26] P
Entries into the open arms 6.556 .005* 0.057 .813 4.000 .031*
% of entries into the open arms 18.101 <.001* 0.173 .681 5.868 .008*
Entries into the closed arms 4.827 .016* 0.094 .761 0.437 .651
Time spent in the open arms 9.612 <.001* 0.835 .369 3.656 .040*
Time spent in closed arms 9.609 <.001* 1.334 .259 1.503 .241
Time spent in the center of the maze 1.226 .310 0.550 .465 1.383 .269
% of distance ran in the closed arms 10.186 <.001* 1.291 .266 6.531 .005*
% of distance ran in the open arms 8.905 .001* 2.412 .133 5.479 .010*
Entries into the ending of the open arms 2.893 .073 1.727 .200 2.566 .096
Time spent into the ending of the open arms 5.420 .011* 4.910 .036* 5.842 .008*
Frequency of head dipping 1.597 .222 1.660 .209 0.440 .649
Head dipping time 3.296 .053 2.143 .155 0.166 .848
Frequency of freezing 5.081 .014* 1.912 .179 3.055 .064
Freezing time 5.648 .009* 1.390 .249 1.412 .262
Frequency of grooming 0.017 .988 0.838 .368 3.690 .039
Grooming time 0.445 .645 0.306 .585 2.193 .132
Frequency of head out 4.119 .028 0.316 .579 2.349 .115
Head out time 1.811 .183 2.197 .150 3.733 .038
Frequency of rearing 0.088 .916 0.981 .331 1.080 .354
Rearing time 1.852 .177 2.460 .129 0.747 .484
Frequency of stretching 2.233 .127 1.944 .175 9.170 <.001*
Stretching time 0.747 .484 7.170 .013* 7.935 .002*
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subjects (p < .05). The Student Newman-Keuls test 
even showed that animals submitted to MCS and 
treated with MDMA entered more into the open 
arms (p < .05) than did animals treated with saline 
or fluoxetine.
ANOVA showed significant differences in the 
percentage of entries into the open arms for the 
treatment condition but not for the stress condition 
(F 
[2, 26]
 = 18.101; p < .001; F 
[1, 26]
 = 0.173; p = .681). 
Figure 1-A shows the percentage of open arms 
entries for all groups. As in the case of entries in-
to the open arms, the interaction between the two 
factors was significant (F 
[2, 26]
 = 5.868; p = .008). 
The post hoc comparison of the averages of the 
groups showed that animals with no exposure to 
MCS and treated with fluoxetine had a higher per-
centage of entries into the open arms. Rats treated 
with MDMA, with or without exposure to MCS 
showed higher percentages of entries into the open 
arms (p < .001) than animals treated with saline or 
fluoxetine. MDMA also increased the percentage of 
entries into the open arms in rats exposed to MCS 
in comparison with rats without MCS exposure 
(p < .01).
In relation with the time spent exploring the 
open arms, ANOVA showed significant differences 
for the treatment condition but not for the stress 
condition (F 
[2, 26]
 = 9.612; p < .001; F 
[1, 26]
 = 0.835; 
p = .369). The interaction between the two factors 
was significant (F 
[2, 26]
 = 3.656; p = .040). The Stu-
dent Newman-Keuls test showed that animals ex-
posed to MCS and treated with MDMA spent more 
time exploring the open arms than animals treated 
with saline solution (p = .001; see Figure 1-B).
ANOVA showed significant differences for 
the treatment but not for the stress condition in 
the amount of entries into the closed arms (F 
[2, 26]
 
= 4.827; p = .016; F 
[1, 26]
 = 0.094; p = .761). The in-
teraction between the factors was not significant (F 
[2, 26]
  = 0.437; p = .651). As a general factor, MDMA 
treated animals entered less into the closed arms. 
ANOVA also showed significant differences in the 
percentage of entries into the closed arms for the 
treatment condition but not for the stress condition. 
The interaction between the factors was significant. 
The post hoc analysis showed that rats treated with 
fluoxetine had greater percentages of entries into 
the closed arms when previously exposed to MCS 
(p < .05). The post hoc comparison also showed 
that animals treated with MDMA had lower per-
centages of entries into the closed arms when pre-
viously exposed to MCS (p < .05). The comparison 
of the averages of the groups also showed that both 
fluoxetine and MDMA decreased the percentage 
of entries into the closed arms for animals without 
stress exposure (p < .05).
Significant differences were also found for the 
treatment condition in the time spent in the closed 
arms but not for the stress condition (F 
[2, 26]
 = 9.609; 
p < .001; F
[1, 26]
 = 1.334; p = .259). The interaction 
between the two factors was not significant (F 
[2, 
26]
 = 1.503; p = .241). As a general effect, animals 
treated with MDMA spent less time exploring the 
closed arms (p < .05). ANOVA showed no signifi-
cant differences for any of the factors in the time 
spent in the center of the maze. The interaction 
between them was also no significant.
Figure 1-C shows the percentages of distance 
traveled within the closed arms. ANOVA showed 
significant differences for the treatment condition 
but not for the stress condition (F 
[2, 26]
  = 10.186; 
p < .001; F 
[1, 26]
 = 1.291; p = .266). The interac-
tion between the two factors was significant (F 
[2, 26]
 = 6.531; p = .005). The post hoc comparison 
of the averages of the groups (Student Newman-
Keuls) showed that animals exposed to the stress 
condition and treated with MDMA had lower per-
centages of distance traveled within the closed arms 
than subjects treated with saline solution (p < .001). 
The post hoc analysis showed that within animals 
treated with MDMA those with MCS exposure 
traveled longer distances in the closed arms than 
those without MCS exposure (p < .05). The post 
hoc comparison also showed that animals treated 
with fluoxetine had higher percentages of clo-
sed arms exploration when pre-exposed to MCS 
(p < .05).
Figure 1-D shows the percentage of distance tra-
veled within the open arms. ANOVA showed signi-
ficant differences for the treatment condition but not 
for the stress condition (F 
[2, 26]
 = 8.905; p < .001; F 
[1, 
26]
 = 2.412; p = .113). The interaction between the two 
factors was significant (F 
[2, 26]
 = 5.479; p = .001). The 
post hoc comparison of the averages of the groups 
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(Student Newman-Keuls) showed that animals ex-
posed to MCS and treated with MDMA explored 
more the open arms than did animals treated with 
saline solution (p = .001). These animals also explo-
red more the open arms than did animals treated with 
the same compound but without MCS pre-exposure 
(p = .007).
ANOVA showed significant differences for 
both treatment and stress condition in the time 
spent exploring the endings of the open arms (see, 
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Figure 1. (a) percentage of open arms entries for all groups; (b) time spent exploring open arms (seconds); (c) 
percentage of distance run in the closed arms; (d) percentage of distance run in the open arms; (e) time spent exploring 
the open arms endings (seconds); (f) time spent stretching the body (seconds). * = different from same stress condition 
but different drug treatment; + = different from same drug treatment but different stress condition. (p < .05).
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Figure 1-E; F 
[2, 26]
 = 5.420; p = .011; F 
[1, 26]
 = 4.910; 
p = .036). The interaction between the two factors 
was also significant (F 
[2, 26]
 = 5.842; p = .008). The 
post hoc comparison of the averages of the groups 
(Student Newman-Keuls) showed that animals ex-
posed to MCS and treated with MDMA explored 
more the open arms endings than did animals trea-
ted with saline solution (p = .003). These animals 
also explored more the open arms endings than 
did animals treated with the same compound but 
without MCS pre-exposure (p = .001).
ANOVA showed no differences for any of the 
factors neither in frequency nor in the time spent 
dipping the head, grooming the body or rearing 
against the walls of the maze. There were found 
significant differences for the treatment condition 
in the frequency of horizontal peeping out of the 
border of the open arms (head out). There were no 
significant differences for the stress condition. The 
interaction between the factors was not significant 
(please refer to Table 1 to see the numeric data). As 
a general effect, animals treated with fluoxetine and 
MDMA showed more horizontal scanning than do 
animals treated with saline solution (p < .05).
There were found no significant differences for 
any of the factors in the frequency of the stretching 
behavior (F 
[2, 26]
 = 2.233; p = .127; F 
[1, 26]
 = 1.944; 
p = .175). However, the interaction between the fac-
tors was significant (F 
[2, 26]
 = 9.170; p < .001). Ani-
mals treated with saline solution and pre-exposed 
to MCS showed an increased amount of flat back 
approaches (p = .008).
Finally, ANOVA showed significant differences 
for the stress condition in the time spent stretching, 
but no for the treatment condition (F 
[2, 26]
 = 0.747; 
p = .484; F 
[1, 26]
 = 7.170; p = .013). The interaction 
between the factors was significant (F 
[2, 26]
 = 7.935; 
p = .002). The post hoc analyses showed that ani-
mals submitted to the stress condition spent less 
time stretching the body when received fluoxetine 
than when received saline solution (p = .03; see 
Figure 1-F).
Discussion
Our data show that subchronic administration of 
MDMA or fluoxetine induce different behavioral 
patterns of exploration in the elevated plus-maze 
in rats previously submitted to a MCS protocol. 
MDMA increased the percentage of entries into the 
open arms in rats both submitted and not submit-
ted to MCS, suggesting an anxiolytic-like effect. 
Interestingly, this anxiolytic-like effect was more 
evident in subjects previously submitted to MCS.
Given the fact that the mechanism of action of 
MDMA involves the massive release and thus the 
extracellular accumulation of 5-HT, the anxiolytic-
like properties of MDMA found here must depend 
on serotonergic mechanisms. In a relatively short 
time (seven days), the enhanced 5-HT levels in-
duced by MDMA led to an anxiolytic-like effect 
while in the same short time fluoxetine seemed 
to have no effect. As earlier mentioned, the acute 
treatment with fluoxetine induces anxiogenic-like 
behaviors while the chronic treatment has the op-
posite effect (Abrams et al., 2005; Alves et al., 
2004; Dos Santos et al., 2008; Silva & Brandao, 
2000; Silva et al., 1999). Here we found that this 
anxiolytic-like effect of fluoxetine was absent in 
subjects previously exposed to MCS, suggesting 
that the dose used here and the amount of time of 
treatment were ineffective to reverse the anxiety 
induced by MCS. However, in animals with no 
exposure to MCS subchronic fluoxetine induced 
the expected anxiolytic effect.
Beside the number of entries into the open arms 
and the time spent exploring them, the pattern of 
exploration of the open arms is a good index of 
anxiety. Animals showing low levels of anxiety 
spent more time actively exploring the open arms 
(Botelho et al., 2007; Cardenas et al., 2001; Gar-
cia et al., 2005). Our data showed that subjects 
submitted to MCS and treated with MDMA spent 
more time in the open arms and explored them mo-
re actively, as reflected by the increased distance 
traveled within them in comparison to the distance 
run within the closed arms. These data suggest 
that MDMA effects are not due to a general motor 
activity enhancement but to an intentional moti-
vation for exploration maybe driven by the richer 
environment offered by the open spaces. The fin-
ding that this particular effect was present only in 
animals submitted to MCS suggest that the 5-HT 
enhancement induced by MCS (Bekris et al., 2005) 
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is added to that induced by MDMA, maybe leading 
to faster changes in 5-HT receptors function and 
expression. This could be the mechanism by which 
MDMA interacts with basal anxiety. The enhanced 
time spent stretching showed by animals submitted 
to MCS suggests a clear increase in anxiety. In fact, 
it has been reported that increased stretching in the 
EPM is related to enhanced plasma corticosterone 
(Albrechet-Souza et al., 2007).
It has been reported that acute increases of 5-HT 
enhance impulsive behavior (Arce & Santisteban, 
2006; Bizot et al., 1999; Dalley et al., 2002; Harri-
son et al., 1997). In the EPM, the exploration of the 
central square has been found to be a good index 
of impulsiveness (Albrechet-Souza et al., 2009; 
Carobrez & Bertoglio, 2005; Griebel et al., 1997; 
Setem et al., 1999; Silva & Brandao, 2000). Our da-
ta showed that neither MDMA nor fluoxetine led to 
changes in the time spent within the central square, 
indicating the absence of any impulsive behavior.
Cunningham et al. showed little anxiety related 
behaviors in the EPM in MDMA pretreated rats. 
It is possible that their stress-inducting procedure 
was “stronger” than ours (Cunningham et al, 2009). 
Their results were interpreted as “unpredictable”. 
However, it should be noted that the dose of MD-
MA used by them is around three times higher than 
the dose used here. Moreover, there are reports 
showing anxiolytic-like effects in the EPM for mi-
ce when using acute MDMA in extremely high (20 
mg/Kg) doses (Lin et al., 1999). These anxiolytic-
like effects could represent impulsive rather than 
anxiolytic-like behavior and could represent an 
inverted-U-shaped-effect for MDMA on anxiety 
with low doses acting as anxiolytic, moderated do-
ses acting as anxiogenic and extremely high doses 
acting as “anxiolytic” or more properly “impulsi-
veness- inductors”.
The amount of time spent in the extremities of 
the open arms has been established as a good in-
dex of anxiety (Cardenas et al., 2001; Estanislau & 
Morato, 2006; Garcia et al., 2005; Martinez et al., 
2007). Both the significant higher time spent into 
the open arms extremities and the huge amount 
of time spent in the whole open arms in MDMA 
MCS [+] subjects, suggest a very low level of 
apprehension. In 1999, King reported an unstable 
elevated plus-maze as a model of extreme anxie-
ty. In her model, the time spent on the open arms 
correlates with an increased level of anxiety. She 
proposed that it could reflect the search for an exit 
of the aversive situation (King, 1999). In our case, 
although MDMA induced an enhancement in 5-HT 
function, the time spent in the open arms could not 
be interpreted as a behavior oriented to the search 
for an exit of the situation mainly because it is not 
correlated to any other anxiety-related responses, 
i.e. decreased dipping of the head or augmented 
stretched flat approaches, as defined by earlier 
works (Cruz et al., 1994). A similar exploratory 
profile was found in rats tested in the absence of 
light (Cardenas et al., 2001; Garcia et al., 2005 ; 
Martinez et al., 2002; Morato & Castrechini, 1989). 
This supports the idea of a specific strong anxiety 
release property for MDMA that could in turn im-
prove coping strategies.
Conclusion
It could be stated that MDMA acts as an enhancer 
of “coping strategies” as expressed by the increased 
exploration of the EPM. The anxiolytic-like effect 
of MDMA suggests a change in the emotional va-
lence of potential aversive stimuli. This reversion 
in the emotional valence was already inferred from 
experiments on emotional memory conducted in 
our laboratory (Leon et al., 2009) and could repre-
sent a coping strategy enhancing effect. It is feasi-
ble that MDMA changes the affective valence of 
stressors in such a way that normal aversive stimuli 
could be “reinterpreted” as normal or even appe-
titive stimuli, maybe by dopaminergic mediation 
(Callaway & Geyer, 1992).
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